skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

DEKRA Certification BV, based in the Netherlands, has been appointed as the fifth notified body under the IVD Regulation.

Its listing under the new regulation, which fully applies from 26 May 2022, appears on the European Commission Nando database of notified bodies designated under the IVDR.  

 IVD manufacturers are being encouraged to have their products assessed as soon as possible under the IVDR; only a small percentage will be able to benefit from the grace period which will allow their products to remain complaint with the IVD Directive up until 26 May 2024, on certain conditions. The vast majority, some 85%, will need to meet the 2022 deadline, and bottlenecks are predicted.

The situation is so acute that the European Commission’s devices expert, Erik Hansson, made a direct plea at the RAPS Euro Convergence meeting for more organizations to apply for IVD Regulation notified body status. Hansson predicted capacity issues this autumn at IVDR designated notified bodies, and into spring of next year.  (Commission Calls For Notified Body Applicants As It Recognizes EU IVD Industry In Some Trouble)

Names Of Other Organizations Designated

The other four notified bodies designated under the IVDR are: BSI Group in the Netherlands, and three German notified bodies: DEKRA Certification GmbH, TÜV Rheinland and TÜV SÜD. This means that all EU notified body IVDR capacity at present is in Germany and the Netherlands.


DEKRA Certification BV has been designated for a very broad range of IVDs types, as well as a long list of horizontal technical competencies such as devices intended to be used as companion diagnostics,and IVD devices which require knowledge of tests of cell function and of parasitology.

It is already designated under the Medical Device Regulation (MDR) and was appointed as a notified body under all three medical device directives.

Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: